tirzepatide mechanism of action vs semaglutide Beyond glycemia: Comparing to GLP-1 analogues | Reviews in Endocrine and Metabolic Disorders Semaglutide and Tirzepatide - How
Description
Ania Jastreboff, an obesity medicine physician scientist at Yale University School of Medicine/Yale School of Medicine, co-Director of the Yale Center for Weight Management and the lead author on the phase 2 study, said that the results were striking and concluded that Retatrutide holds promise for substantial weight reduction in adults with obesity over a 48-week period

Thats a problem, because obesity is a chronic disease
We do not prescribe compounded drugs

doi: 10.1679/aohc.66.253

Some patients experience fatigue when first starting semaglutide

The British Heart Foundation highlights risks including pancreatitis, vision loss, and nutritional deficiencies
